The diagnostic accuracy of the Forns index, platelet count and AST to Platelet Ratio Index derived fibrosis index for the prediction of Hepatitis C virus-related significant liver fibrosis and cirrhosis. (April 2014)
- Record Type:
- Journal Article
- Title:
- The diagnostic accuracy of the Forns index, platelet count and AST to Platelet Ratio Index derived fibrosis index for the prediction of Hepatitis C virus-related significant liver fibrosis and cirrhosis. (April 2014)
- Main Title:
- The diagnostic accuracy of the Forns index, platelet count and AST to Platelet Ratio Index derived fibrosis index for the prediction of Hepatitis C virus-related significant liver fibrosis and cirrhosis
- Authors:
- Kayadibi, Huseyin
Yasar, Bulent
Ozkara, Selvinaz
Serdar, Muhittin A.
Kurdas, Oya O.
Gonen, Can - Abstract:
- <abstract> <title>Abstract</title> <p> <bold> <italic>Aim</italic>.</bold> To provide a simple fibrosis index combining the routine laboratory markers for predicting significant fibrosis (SF) and cirrhosis in patients with chronic HCV. <bold><italic>Methods</italic>.</bold> Platelet count, ALT, AST, AST to ALT Ratio, AST to Platelet Ratio Index (APRI), Forns index, FIB-4 and Age Platelet Index of 202 liver biopsy performed HCV-infected patients were reviewed. METAVIR classification was used to determine the stage of liver fibrosis. The predictive fibrosis index was constructed by multiple linear regression analysis (− 2.948 + 0.562 × Forns index + 0.288 × APRI + 0.006 × platelet count [10<sup>9</sup>/L]). <bold><italic>Results</italic>.</bold> Median (25th–75th interquartile range) age was 52 (42–59) years, and 61% were male. 65.8% (<italic>n</italic> = 133) had SF (F2–F4) and 23.3% (<italic>n</italic> = 47) had cirrhosis (F4). For discrimination of SF, AUROCs were: Fibrosis index = 0.869, Forns index = 0.837, APRI = 0.814, platelet count = 0.764. For cirrhosis, AUROCs were: Fibrosis index = 0.911, Forns index = 0.883, APRI = 0.847, platelet count = 0.827. A cut-off point of ≤ 1.2 for fibrosis index excluded SF in 89% of patients with sensitivity of 96%, while &gt; 2.0 predicted SF in 88% of patients with specificity of 86%. Threshold of ≤ 1.9 excluded cirrhosis in 95% of patients with sensitivity of 94%, while &gt; 2.7 showed cirrhosis in 88% of patients with specificity of<abstract> <title>Abstract</title> <p> <bold> <italic>Aim</italic>.</bold> To provide a simple fibrosis index combining the routine laboratory markers for predicting significant fibrosis (SF) and cirrhosis in patients with chronic HCV. <bold><italic>Methods</italic>.</bold> Platelet count, ALT, AST, AST to ALT Ratio, AST to Platelet Ratio Index (APRI), Forns index, FIB-4 and Age Platelet Index of 202 liver biopsy performed HCV-infected patients were reviewed. METAVIR classification was used to determine the stage of liver fibrosis. The predictive fibrosis index was constructed by multiple linear regression analysis (− 2.948 + 0.562 × Forns index + 0.288 × APRI + 0.006 × platelet count [10<sup>9</sup>/L]). <bold><italic>Results</italic>.</bold> Median (25th–75th interquartile range) age was 52 (42–59) years, and 61% were male. 65.8% (<italic>n</italic> = 133) had SF (F2–F4) and 23.3% (<italic>n</italic> = 47) had cirrhosis (F4). For discrimination of SF, AUROCs were: Fibrosis index = 0.869, Forns index = 0.837, APRI = 0.814, platelet count = 0.764. For cirrhosis, AUROCs were: Fibrosis index = 0.911, Forns index = 0.883, APRI = 0.847, platelet count = 0.827. A cut-off point of ≤ 1.2 for fibrosis index excluded SF in 89% of patients with sensitivity of 96%, while &gt; 2.0 predicted SF in 88% of patients with specificity of 86%. Threshold of ≤ 1.9 excluded cirrhosis in 95% of patients with sensitivity of 94%, while &gt; 2.7 showed cirrhosis in 88% of patients with specificity of 95%. In multivariate logistic regression analysis, OR (95% CI) of fibrosis index was 7.825 (3.682–16.629) for SF (<italic>p</italic> &lt; 0.001) and was 8.672 (4.179–17.996) for cirrhosis (<italic>p</italic> &lt; 0.001). <bold><italic>Conclusion</italic>.</bold> SF and cirrhosis were predicted with accuracy of 82% and 89% and were excluded with accuracy of 74% and 82% using this fibrosis index which may potentially decrease the need for liver biopsy in 76% and 83% of patients, respectively.</p> </abstract> … (more)
- Is Part Of:
- Scandinavian journal of clinical & laboratory investigation. Volume 74:Number 3(2014)
- Journal:
- Scandinavian journal of clinical & laboratory investigation
- Issue:
- Volume 74:Number 3(2014)
- Issue Display:
- Volume 74, Issue 3 (2014)
- Year:
- 2014
- Volume:
- 74
- Issue:
- 3
- Issue Sort Value:
- 2014-0074-0003-0000
- Page Start:
- 240
- Page End:
- 247
- Publication Date:
- 2014-04
- Subjects:
- Clinical biochemistry -- Periodicals
Physiology, Pathological -- Periodicals
Physiology, Experimental -- Periodicals
Medicine -- Research -- Periodicals
Clinical medicine -- Periodicals
616.0072 - Journal URLs:
- http://informahealthcare.com/loi/clb ↗
http://informahealthcare.com ↗ - DOI:
- 10.3109/00365513.2013.879392 ↗
- Languages:
- English
- ISSNs:
- 0036-5513
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 8087.500000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 4035.xml